SON-DP in Participants with Relapsed/Refractory Intolerant to Standard of Care Therapies for Advanced/Metastatic Solid Tumors
- First Posted Date
- 2025-03-13
- Last Posted Date
- 2025-03-13
- Lead Sponsor
- Qurgen Inc.
- Target Recruit Count
- 96
- Registration Number
- NCT06873659
- Locations
- 🇨🇳
Cancer Hospital Chinese Academy of Medical Sciences, Beijing, Beijing, China
🇨🇳Beijing Cancer Hospital, Beijing, Beijing, China
🇨🇳Jiangsu Province Hospital, Nanjing, Jiangsu, China
A First-in-Human Study of SON-DP in Participants With Relapsed/Refractory Intolerant to Standard of Care Therapies for Advanced/Metastatic Solid Tumors
Phase 1
Recruiting
- Conditions
- Solid TumorBreast CancerPancreatic CancerOvarian CancerColorectal Cancer
- Interventions
- First Posted Date
- 2023-08-14
- Last Posted Date
- 2024-04-24
- Lead Sponsor
- Qurgen Inc.
- Target Recruit Count
- 150
- Registration Number
- NCT05989724
- Locations
- 🇺🇸
Banner MD Anderson Cancer Center (BMDACC), Gilbert, Arizona, United States
🇺🇸Henry Ford Health System, Detroit, Michigan, United States
🇺🇸Carolina BioOncology Institute, Huntersville, North Carolina, United States